C Buscarino Selected Research

OspA protein

07/2001	Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial.
03/2000	Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months.

2	Lyme Disease (Disease, Lyme) 07/2001 - 03/2000

2	OspA proteinIBA 07/2001 - 03/2000